Pharmafile Logo
Pharmafocus logo
Advanced Search

Professional regulation – a DIY job?

May 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPD, GMC, Les Rose, drug discovery, regulation

What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …

Feature

Lilly invests in UK research base

May 2, 2012
Research and Development Elil Lilly, Erl Wood, neuroscience

Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …

News
Ian Read

Lipitor losses hit Pfizer

May 2, 2012
Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry

Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …

News

SHL to speak & exhibit at the PDA’s upcoming Prefilled Syringe Seminar in Japan

May 2, 2012
Manufacturing and Production auto injector, autoinjector, pda japan, prefilled syringe

SHL to speak & exhibit at the PDA’s upcoming Prefilled Syringe Seminar in Tokyo, Japan May 22nd-23rd 2012 Auto injectors …

News
Press release

Targacept cuts workforce

May 1, 2012
Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept

The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …

News

EMA eSubmission Gateway now live

May 1, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; ectd

Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …

News
Press release

Novartis will restart production at Lincoln plant in May

May 1, 2012
Manufacturing and Production FDA, GMP, Lincoln, Nebraska, Novartis, manufacturing

Novartis chief executive Joe Jimenez has said that production at the firm’s troubled consumer health plant in Lincoln, Nebraska, will …

News
FDA picture

FDA approves greener process for Januvia production

May 1, 2012
Manufacturing and Production Codexis, FDA, Januvia, Merck, manufacturing

The US Food and Drug Administration (FDA) has approved a new, more environmentally-friendly manufacturing process for Merck & Co’s diabetes …

News

Pharma manufacturing news in brief

May 1, 2012
Manufacturing and Production Aptar Pharma, Ark Therapeutics, Cambrex, Eckert & Ziegler, Granules India and Omkar Speciality Chemicals

Cambrex facility passes FDA inspection, low-cost inhaler launched by Aptar, plus updates from Eckert & Ziegler, Granules India and Omkar …

News

Contract research news in brief

May 1, 2012
Research and Development BML, Cetero Labs, Covance, Harlan and Chiltern, PRA

A round-up of recent developments in the contract research sector, featuring updates from PRA, Cetero Labs, Covance/BML, Harlan Labs CRS …

News

Actelion boosted by trial success

April 30, 2012
Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan

Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial.  The news comes after …

News
Votrient image

FDA approves GSK’s Votrient for new licence

April 30, 2012
Sales and Marketing Cancer, FDA Approval, GSK, Votrient

The FDA has approved GlaxoSmithKline’s cancer pill Votrient for the treatment of a rare group of cancers – but has …

News

New ABPI president appointed

April 30, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, MSD UK, appointment

Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the …

Appointment
FDA picture

FDA approves new erectile dysfunction drug

April 30, 2012
Sales and Marketing ED, FDA, Stendra. Pfizer, Vivus, viagra

The FDA has approved Vivus’ erectile dysfunction drug Stendra, and the firm hopes its rapid mode of action will help …

News
Benlysta image

NICE no to GSK’s lupus drug Benlysta

April 27, 2012
Sales and Marketing Andrew Dillon, Benlysta, GSK, Lupus, NICE

NICE is still not recommending GlaxoSmithKline’s lupus drug Benlysta, as it believes the treatment is too costly.  In its final …

News
screen_shot_2012-04-27_at_10

Novartis right to challenge NHS on Avastin use – ABPI chief

April 27, 2012
Sales and Marketing ABPI, Lucentis, Whitehead, avastin, wet AMD

The ABPI has declared its support for Novartis in its legal challenge against off-label prescribing in England.The pharma company is …

News

New head at Bayer’s Animal Health division

April 27, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer Healthcare, Dirk Ehle, animal health

Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer.  The 42-year-old succeeds Dr Jean-Luc Lowinski, …

Appointment

Watson buys Actavis to create generics giant

April 27, 2012
Sales and Marketing Actavis, Watson, generics

Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …

News

Brennan bows to pressure and quits AstraZeneca

April 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma

AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …

News

Novartis Q1 earnings slide down

April 26, 2012
Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya

Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026